Blood eosinophil counts predict treatment response in patients with severe eosinophilic asthma

J Allergy Clin Immunol. 2015 Sep;136(3):825-6. doi: 10.1016/j.jaci.2015.05.039. Epub 2015 Jul 17.

Authors

Hector Ortega¹, Lynn Katz², Necdet Gunsoy³, Oliver Keene³, Steven Yancey²

Affiliations

¹ Respiratory Therapeutic Area, GlaxoSmithKline, Research Triangle Park, NC. Electronic address: hector.g.ortega@gsk.com.
² Respiratory Therapeutic Area, GlaxoSmithKline, Research Triangle Park, NC.
³ Clinical Statistics, GlaxoSmithKline, Stockley Park, United Kingdom.

PMID: 26194540
DOI: 10.1016/j.jaci.2015.05.039

No abstract available

Publication types

Letter
Comment

MeSH terms

Asthma / diagnosis*
Asthma / pathology*
Eosinophilia / diagnosis*
Eosinophilia / pathology*
Eosinophils / pathology*
Humans